Selskabets formål er at drive virksomhed med rådgivning som serviceydelse, samt enhver i forbindelse hermed stående virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.9 mio. | 592 t. | 999 t. | 634 t. | - | |
CVR: 42398993
Compared to 1.981 companies in Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder
Comparison is based on industry median values
The financial health of JR Pharma Engineering ApS appears stable, with consistent profitability over the past four years. Revenue has shown a slight upward trend, increasing from 1,481,600 DKK in 2022 to 1,925,862 DKK in 2025, while profit margins have remained relatively strong, peaking at 650,721 DKK in 2024. Equity has also grown from 615,092 DKK in 2022 to 633,571 DKK in 2025, indicating a solid capital position. However, the slight decline in profit from 650,721 DKK in 2024 to 591,630 DKK in 2025 may raise concerns about future profitability. Overall, the company maintains a modest but stable position within the engineering consulting sector.
AI-generated summary
Companies in the same industry and area
CVR 44531836
CVR 42457566
CVR 45313581
CVR 29083088
CVR 27161472
companydata.dk